As of January 2026 Neuphoria Therapeutics has a market cap of A$32.88 Million. This makes Neuphoria Therapeutics the world's 10132th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 19th, 2026 the market cap of Neuphoria Therapeutics was reported to be: